A detailed history of Susquehanna International Group, LLP transactions in Dexcom Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 110,535 shares of DXCM stock, worth $8.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
110,535
Previous 130,946 15.59%
Holding current value
$8.6 Million
Previous $14.8 Million 50.1%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$64.0 - $116.06 $1.31 Million - $2.37 Million
-20,411 Reduced 15.59%
110,535 $7.41 Million
Q2 2024

Aug 15, 2024

SELL
$110.31 - $140.45 $8.76 Million - $11.2 Million
-79,437 Reduced 37.76%
130,946 $14.8 Million
Q1 2024

May 07, 2024

BUY
$114.22 - $140.1 $60,079 - $73,692
526 Added 0.25%
210,383 $29.2 Million
Q4 2023

Feb 14, 2024

BUY
$75.49 - $124.16 $2.15 Million - $3.54 Million
28,510 Added 15.72%
209,857 $26 Million
Q3 2023

Nov 14, 2023

BUY
$86.06 - $137.93 $924,370 - $1.48 Million
10,741 Added 6.3%
181,347 $16.9 Million
Q2 2023

Aug 11, 2023

SELL
$112.47 - $130.98 $15.6 Million - $18.2 Million
-138,917 Reduced 44.88%
170,606 $21.9 Million
Q1 2023

May 16, 2023

SELL
$104.0 - $122.92 $36.1 Million - $42.6 Million
-346,722 Reduced 52.83%
309,523 $36 Million
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $48.2 Million - $69.6 Million
567,362 Added 638.32%
656,245 $74.3 Million
Q3 2022

Nov 14, 2022

SELL
$76.35 - $94.18 $9.41 Million - $11.6 Million
-123,232 Reduced 58.1%
88,883 $7.16 Million
Q2 2022

Aug 15, 2022

SELL
$67.99 - $132.89 $1.68 Million - $3.29 Million
-24,739 Reduced 10.44%
212,115 $15.8 Million
Q1 2022

May 16, 2022

SELL
$94.08 - $130.2 $1.51 Million - $2.1 Million
-16,097 Reduced 6.36%
236,854 $121 Million
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $28.1 Million - $35.2 Million
216,329 Added 590.71%
252,951 $136 Million
Q3 2021

Nov 15, 2021

SELL
$106.71 - $143.18 $4.51 Million - $6.06 Million
-42,302 Reduced 53.6%
36,622 $20 Million
Q2 2021

Aug 11, 2021

BUY
$80.99 - $107.93 $507,159 - $675,857
6,262 Added 8.62%
78,924 $33.7 Million
Q1 2021

May 17, 2021

SELL
$84.79 - $104.74 $8.02 Million - $9.91 Million
-94,637 Reduced 56.57%
72,662 $26.1 Million
Q4 2020

Feb 16, 2021

BUY
$78.0 - $104.5 $7.94 Million - $10.6 Million
101,838 Added 155.57%
167,299 $61.9 Million
Q3 2020

Nov 16, 2020

SELL
$95.51 - $112.95 $9.24 Million - $10.9 Million
-96,739 Reduced 59.64%
65,461 $27 Million
Q2 2020

Aug 14, 2020

BUY
$62.68 - $105.34 $2.91 Million - $4.9 Million
46,505 Added 40.2%
162,200 $65.8 Million
Q1 2020

May 15, 2020

BUY
$47.79 - $75.63 $3.01 Million - $4.76 Million
62,894 Added 119.12%
115,695 $31.2 Million
Q4 2019

Feb 14, 2020

BUY
$36.62 - $57.29 $893,894 - $1.4 Million
24,410 Added 85.98%
52,801 $11.6 Million
Q3 2019

Nov 14, 2019

SELL
$35.53 - $43.8 $2.2 Million - $2.71 Million
-61,906 Reduced 68.56%
28,391 $4.24 Million
Q2 2019

Aug 16, 2019

BUY
$27.84 - $38.92 $548,670 - $767,035
19,708 Added 27.92%
90,297 $13.5 Million
Q2 2019

Aug 14, 2019

SELL
$27.84 - $38.92 $1.11 Million - $1.55 Million
-39,740 Reduced 36.02%
70,589 $10.6 Million
Q1 2019

May 15, 2019

BUY
$28.07 - $38.18 $1.67 Million - $2.28 Million
59,663 Added 117.76%
110,329 $13.1 Million
Q4 2018

Feb 14, 2019

BUY
$26.99 - $37.37 $1.33 Million - $1.84 Million
49,114 Added 3164.56%
50,666 $6.07 Million
Q3 2018

Nov 14, 2018

SELL
$23.35 - $36.72 $610,182 - $959,567
-26,132 Reduced 94.39%
1,552 $222,000
Q2 2018

Aug 14, 2018

SELL
$17.54 - $25.22 $1.54 Million - $2.21 Million
-87,602 Reduced 75.99%
27,684 $2.63 Million
Q4 2017

Feb 14, 2018

SELL
$11.12 - $15.38 $323,013 - $446,758
-29,048 Reduced 20.13%
115,286 $6.62 Million
Q3 2017

Nov 14, 2017

BUY
$11.36 - $18.98 $1.64 Million - $2.74 Million
144,334
144,334 $7.06 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.